Standard BioTools Inc. (LAB) Short-Term Debt to Capital

Symbol and logo of brand fluidigm.com (LAB)

This daily price chart for Standard BioTools Inc. (LAB) reflects the asset's dynamics, with a value of 0.01. Standard BioTools Inc. (LAB) supplies microfluidics systems to global pharma behemoths and biotech firms, protecting profits through a broad customer base. Standard BioTools Inc. (LAB) also generates revenue by developing equipment for genome and cell research. The business is currently implementing automated stations that eliminate human error during sample preparation.

LAB Standard BioTools Inc: Short-Term Debt to Capital Ratio in the range 04/28/2023 - 10/27/2026

Metric breakdowns and analytics for fluidigm.com (LAB)

- price and consensus price forecast:
Stock Price Fluidigm|LAB - Broker Consensus Forecast
- market capitalization data:
Market Capitalization Standard BioTools Inc|LAB - Enterprise Value
- book capitalization data:
Net Assets per Single Share Standard BioTools|LAB - Accounting Capitalization|Market Capitalization to Book Value Ratio fluidigm.com|LAB - Company Total Assets
- debt and liquidity data:
Debt to Equity Standard BioTools Inc.|LAB - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Standard BioTools|LAB - Company Cumulative Debt|Debt to Book Capitalization Ratio Standard BioTools Inc
General company analysis:Fluidigm, LAB
Signature product of Standard BioTools Inc

Finding a balance between operational risks and return on equity requires an analysis of the debt load of Standard BioTools (LAB), whose scientific reputation in bio-research attracts institutional capital. This ratio of loans under one year to equity measures the share of short-term liabilities within the asset structure, allowing for an assessment of the business's current solvency and financial stability as commercial confidence recovers.

Analysis of competing companies

Short-Term Debt to Capital Agilent Tech A|Short-Term Debt to Capital Ratio Quest Corp (DGX)|Short-Term Debt to Capital ILMN (Illumina, Inc.)|exactsciences.com - Short-Term Debt to Capital|Revvity (RVTY) - Short-Term Debt to Equity|BIO - Short-Term Debt to Capital Ratio|NNNN: Short-Term Debt to Capital|SHC (Nordion) - Short-Term Debt to Capital|Short-Term Debt to Equity QuidelOrtho|Short-Term Debt to Equity opko.com (OPK)|CareDx Health - Short-Term Debt to Equity Ratio|Current Liabilities to Capital MRVI (Maravai LifeSciences Holdings)|Short-Term Debt to Equity FLGT|Short-Term Debt to Capital Coefficient Cytek Corp CTKB|Short-Term Debt to Capital OSUR (OraSure Technologies)|XGN: Short-Term Debt to Capital Coefficient|MDxHealth - Short-Term Debt to Equity|LUCD (Lucid Diagnostics, Inc.) - Short-Term Debt to Capital Coefficient|PRE: Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Insight Molecular (IMDX)|Short-Term Debt to Equity Ratio Trinity Biotech plc|Short-Term Loans to Capital Ratio prophaselabs.com (PRPH)|Short-Term Debt to Capital AIMD (Ainos)|Co-Diagnostics Inc - Short-Term Debt to Capital|Heart Test Laboratories Inc. (HSCS) - Short-Term Debt to Equity|BMRA - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital cardiodiagnosticsinc.com|viraxbiolabs.com (VRAX) - Short-Term Debt to Capital Ratio|BJDX (Bluejay Diagnostics, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital AWH|Accelerate Diagnostics, Inc (AXDX) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Centogene (CNTG)|ENZ - Short-Term Debt to Capital|FRES - Short-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio GTG Labs (GENE)|ME - Ratio of Short-Term Indebtedness to Capital|Psychemedics Corp (PMD) - Short-Term Debt to Capital